Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice
Pedro H. Reis‐Barbosa, Ilitch Aquino Marcondes‐de‐Castro, Thatiany de Souza Marinho, et al.
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 6, pp. 101922-101922
Closed Access | Times Cited: 25

Showing 25 citing articles:

Semaglutide (GLP‐1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice
Fabiane Ferreira Martins, Thatiany de Souza Marinho, Luiz E.M. Cardoso, et al.
Cell Biochemistry and Function (2022) Vol. 40, Iss. 8, pp. 903-913
Closed Access | Times Cited: 42
AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression
Ilitch Aquino Marcondes‐de‐Castro, Pedro H. Reis‐Barbosa, Thatiany de Souza Marinho, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 11, pp. 1868-1876
Open Access | Times Cited: 25
Metabolites of Clostridium leptum fermenting flaxseed polysaccharide alleviate obesity in rats
Tianxing Li, Minjian Liang, Jianming Luo, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 129907-129907
Closed Access | Times Cited: 8
A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK)
C. Mary Schooling, Guoyi Yang, Ghada A. Soliman, et al.
Life (2025) Vol. 15, Iss. 2, pp. 253-253
Open Access | Times Cited: 1
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access | Times Cited: 1
The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK/mTOR/lipogenesis Pathways
Ghaleb A. Oriquat, Inas M. Masoud, Maher A. Kamel, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1734-1734
Open Access | Times Cited: 15
Liraglutide Improves Nonalcoholic Fatty Liver Disease in Diabetic Mice by Activating Autophagy Through AMPK/mTOR Signaling Pathway
Zhanlin Liao, Liangzhi Huang, Jun Chen, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 575-584
Open Access | Times Cited: 5
AMPK-Mediated Multi-Organ Protective Effects of GLP-1 Receptor Agonists
Xin Wang, Linxi Wang
(2025), pp. 4-4
Closed Access
Brown adipose tissue as an endocrine organ: updates on the emerging role of batokines
Fabiane Ferreira Martins, Vanessa Souza‐Mello, Márcia Barbosa Águila, et al.
Hormone Molecular Biology and Clinical Investigation (2022) Vol. 44, Iss. 2, pp. 219-227
Closed Access | Times Cited: 16
Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats
Simon Kloock, Niklas Haerting, G. Herzog, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 904-904
Open Access | Times Cited: 3
Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease
Chara Tsiampali, Ilias D. Vachliotis, A. Goulas, et al.
HORMONES (2024) Vol. 23, Iss. 4, pp. 611-619
Open Access | Times Cited: 3
Sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) plus glucagon‐like peptide type 1 receptor combination is more effective than SGLT2i plus dipeptidyl peptidase‐4 inhibitor combination in treating obese mice metabolic dysfunction‐associated steatotic liver disease (MASLD)
Pedro H. Reis‐Barbosa, Carlos Alberto Mandarim‐de‐Lacerda
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 6, pp. 1059-1068
Closed Access | Times Cited: 3
Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review
Sultan A. Alfawaz, Abdulhadi S. Burzangi, Ahmed Esmat
Cureus (2024)
Open Access | Times Cited: 3
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations
Panagiotis Theofilis, Aikaterini Vordoni, Rigas Kalaitzidis
World Journal of Gastroenterology (2022) Vol. 28, Iss. 39, pp. 5691-5706
Open Access | Times Cited: 14
Beneficial effects of simultaneously targeting calorie intake and calorie efficiency in diet-induced obese mice
Sing-Young Chen, Aiden J. Telfser, Ellen M. Olzomer, et al.
Clinical Science (2024) Vol. 138, Iss. 4, pp. 173-187
Open Access | Times Cited: 2
Exploring the antioxidant properties of semaglutide: A comprehensive review
Habib Yaribeygi, Mina Maleki, Behina Forouzanmehr, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 12, pp. 108906-108906
Closed Access | Times Cited: 1
Cardioprotective antihyperglycemic drugs ameliorate endoplasmic reticulum stress
Arshag D. Mooradian, Michael J. Haas
AJP Cell Physiology (2023) Vol. 326, Iss. 1, pp. C89-C94
Closed Access | Times Cited: 3
The obesity and nonalcoholic fatty liver disease mouse model revisited: Liver oxidative stress, hepatocyte apoptosis, and proliferation
Pedro H. Reis‐Barbosa, Thatiany de Souza Marinho, Cristiane Matsuura, et al.
Acta Histochemica (2022) Vol. 124, Iss. 7, pp. 151937-151937
Closed Access | Times Cited: 5
Adult mice offspring of obese mothers supplemented with melatonin show lessened liver steatosis, inflammation, oxidative stress, and endoplasmic reticulum stress
Matheus Ajackson, Brenda A. Nagagata, Ilitch Aquino Marcondes‐de‐Castro, et al.
Life Sciences (2022) Vol. 312, pp. 121253-121253
Open Access | Times Cited: 4
Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report
Jean‐Baptiste Bonnet, Axelle Trupheme Durieux, Sarah Tournayre, et al.
Obesity Research & Clinical Practice (2024) Vol. 18, Iss. 2, pp. 159-162
Open Access
PBAT-modified starch blended film extract induces in vitro toxicity in L-02 cells: induction of oxidative stress, inflammation, and modulation of AMPK pathway
Congying Chen, Xueman Xiao, Yifeng Rang, et al.
Drug and Chemical Toxicology (2024) Vol. 47, Iss. 6, pp. 1139-1154
Closed Access
Glucagon, Metabolic Dysfunction-Associated Steatotic Liver Disease and Amino Acids in Humans and Animals without Diabetes Mellitus—An Evidence Map
Katharina Maruszczak, Pia Koren, Konrad Radzikowski, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1292-1292
Open Access
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11299-11299
Open Access
Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice
Fang Lv, Xiaoling Cai, Chu Lin, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1655-1655
Open Access
As Batocinas, Adipocinas Secretadas pelo Tecido Adiposo Marrom
Fabiane Ferreira Martins, Carlos Alberto Mandarim‐de‐Lacerda
Anais da Academia Nacional de Medicina (2022) Vol. 193, Iss. 2, pp. 65-76
Open Access | Times Cited: 1
Page 1

Scroll to top